STARC
Jump to navigation
Jump to search
Redirect to:
Angioplasty/Atherectomy/Laser Therapy: Trapidil (Triazolopyrimidine), A Platelet-Derived Growth Factor Antagonist, Reduces Restenosis After Percutaneous Transluminal Coronary Angioplasty: Results Of The Randomized, Double-Blind Starc Study
Category
:
Clinical trials
Cookies help us deliver our services. By using our services, you agree to our use of cookies.
OK
Navigation menu
Personal tools
Log in
Request account
Namespaces
Page
Discussion
English
Views
Read
View source
View history
More
Search
Tools
What links here
Related changes
Printable version
Permanent link
Page information